GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.98 $5.74 Wednesday, 17th Apr 2024 VTGN stock ended at $4.67. This is 0.430% more than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 3.00% from a day low at $4.66 to a day high of $4.80.
90 days $3.91 $5.74
52 weeks $1.62 $24.71

Historical VistaGen Therapeutics Inc prices

Date Open High Low Close Volume
2023-10-17 $3.34 $3.58 $3.15 $3.40 1 199 864
2023-10-16 $3.44 $3.47 $3.08 $3.17 640 393
2023-10-13 $3.39 $3.62 $3.33 $3.44 323 158
2023-10-12 $3.36 $3.47 $3.19 $3.35 290 793
2023-10-11 $3.75 $3.75 $3.35 $3.37 411 624
2023-10-10 $3.58 $3.85 $3.55 $3.70 343 219
2023-10-09 $3.40 $3.56 $3.31 $3.55 400 864
2023-10-06 $3.24 $3.76 $3.02 $3.63 1 178 307
2023-10-05 $3.44 $3.56 $3.12 $3.12 1 445 177
2023-10-04 $3.89 $3.97 $3.42 $3.43 1 076 699
2023-10-03 $4.37 $4.37 $3.76 $3.87 1 108 547
2023-10-02 $4.89 $4.89 $4.00 $4.20 1 836 389
2023-09-29 $5.18 $5.30 $5.08 $5.24 93 757
2023-09-28 $5.18 $5.37 $5.02 $5.18 202 199
2023-09-27 $5.31 $5.61 $5.16 $5.27 123 486
2023-09-26 $5.29 $5.71 $5.25 $5.36 218 560
2023-09-25 $5.21 $5.35 $5.10 $5.30 180 413
2023-09-22 $5.15 $5.33 $5.07 $5.25 158 302
2023-09-21 $5.10 $5.29 $5.08 $5.15 143 783
2023-09-20 $5.60 $5.62 $5.18 $5.19 245 098
2023-09-19 $5.60 $5.72 $5.48 $5.60 207 150
2023-09-18 $5.90 $5.94 $5.65 $5.68 224 263
2023-09-15 $6.09 $6.23 $5.94 $5.95 304 852
2023-09-14 $6.03 $6.38 $5.97 $6.15 190 974
2023-09-13 $6.37 $6.48 $5.79 $6.02 383 450
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT